BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Iersel L, Brokke KE, Adan RAH, Bulthuis LCM, van den Akker ELT, van Santen HM. Pathophysiology and Individualized Treatment of Hypothalamic Obesity Following Craniopharyngioma and Other Suprasellar Tumors: A Systematic Review. Endocr Rev 2019;40:193-235. [PMID: 30247642 DOI: 10.1210/er.2018-00017] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Nuijts MA, Veldhuis N, Stegeman I, van Santen HM, Porro GL, Imhof SM, Schouten-van Meeteren AYN. Visual functions in children with craniopharyngioma at diagnosis: A systematic review. PLoS One 2020;15:e0240016. [PMID: 33002047 DOI: 10.1371/journal.pone.0240016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 van Roessel IMAA, van Schaik J, Meeteren AYNS, Boot AM, der Grinten HLC, Clement SC, van Iersel L, Han KS, van Trotsenburg ASP, Vandertop WP, Kremer LCM, van Santen HM. Body mass index at diagnosis of a childhood brain tumor; a reflection of hypothalamic-pituitary dysfunction or lifestyle? Support Care Cancer 2022. [PMID: 35416504 DOI: 10.1007/s00520-022-07031-4] [Reference Citation Analysis]
3 Hamblin R, Tsermoulas G, Karavitaki N. Craniopharyngiomas. Presse Med 2021;50:104078. [PMID: 34688870 DOI: 10.1016/j.lpm.2021.104078] [Reference Citation Analysis]
4 Kleinendorst L, Abawi O, van der Voorn B, Jongejan MHTM, Brandsma AE, Visser JA, van Rossum EFC, van der Zwaag B, Alders M, Boon EMJ, van Haelst MM, van den Akker ELT. Identifying underlying medical causes of pediatric obesity: Results of a systematic diagnostic approach in a pediatric obesity center. PLoS One 2020;15:e0232990. [PMID: 32384097 DOI: 10.1371/journal.pone.0232990] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Prieto R, Rosdolsky M, Hofecker V, Barrios L, Pascual JM. Craniopharyngioma treatment: an updated summary of important clinicopathological concepts. Expert Rev Endocrinol Metab 2020;15:261-82. [PMID: 32615875 DOI: 10.1080/17446651.2020.1770081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 van Schaik J, Begijn DGA, van Iersel L, Vergeer Y, Hoving EW, Peeters B, van Santen HM. Experiences with Glucagon-Like Peptide-1 Receptor Agonist in Children with Acquired Hypothalamic Obesity. Obes Facts 2020;13:361-70. [PMID: 32781455 DOI: 10.1159/000509302] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Horne VE, Bielamowicz K, Nguyen J, Hilsenbeck S, Lindsay H, Sonabend R, Wood AC, Okcu F, Sisley S. Methylphenidate improves weight control in childhood brain tumor survivors with hypothalamic obesity. Pediatr Blood Cancer 2020;67:e28379. [PMID: 32383818 DOI: 10.1002/pbc.28379] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Müller HL. Management of Hypothalamic Obesity. Endocrinol Metab Clin North Am 2020;49:533-52. [PMID: 32741487 DOI: 10.1016/j.ecl.2020.05.009] [Reference Citation Analysis]
9 Boekhoff S, Bison B, Eveslage M, Sowithayasakul P, Müller HL. Craniopharyngiomas presenting as incidentalomas: results of KRANIOPHARYNGEOM 2007. Pituitary 2019;22:532-41. [PMID: 31440945 DOI: 10.1007/s11102-019-00983-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
10 Singhal V, Sella AC, Malhotra S. Pharmacotherapy in pediatric obesity: current evidence and landscape. Curr Opin Endocrinol Diabetes Obes 2021;28:55-63. [PMID: 33186194 DOI: 10.1097/MED.0000000000000587] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Huang CC, Lin KL, Wu CT, Jung SM, Wang CJ, Chen YC, Lo FS. Clinical and endocrinological manifestations of childhood-onset craniopharyngioma before surgical removal: A report from one medical center in Taiwan. Pediatr Neonatol 2021;62:181-6. [PMID: 33376065 DOI: 10.1016/j.pedneo.2020.08.014] [Reference Citation Analysis]
12 Kumar U, Singh S. Role of Somatostatin in the Regulation of Central and Peripheral Factors of Satiety and Obesity. Int J Mol Sci 2020;21:E2568. [PMID: 32272767 DOI: 10.3390/ijms21072568] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Romigi A, Feola T, Cappellano S, De Angelis M, Pio G, Caccamo M, Testa F, Vitrani G, Centonze D, Colonnese C, Esposito V, Jaffrain-rea M. Sleep Disorders in Patients With Craniopharyngioma: A Physiopathological and Practical Update. Front Neurol 2022;12:817257. [DOI: 10.3389/fneur.2021.817257] [Reference Citation Analysis]
14 Müller HL. Bariatric Interventions in Craniopharyngioma Patients-Best Choice or Last Option for Treatment of Hypothalamic Obesity? J Clin Endocrinol Metab 2022;107:e426-8. [PMID: 34331765 DOI: 10.1210/clinem/dgab567] [Reference Citation Analysis]
15 van Schaik J, Welling MS, de Groot CJ, van Eck JP, Juriaans A, Burghard M, Oude Ophuis SBJ, Bakker B, Tissing WJE, Schouten-van Meeteren AYN, van den Akker ELT, van Santen HM. Dextroamphetamine Treatment in Children With Hypothalamic Obesity. Front Endocrinol 2022;13:845937. [DOI: 10.3389/fendo.2022.845937] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Craven M, Crowley JH, Chiang L, Kline C, Malbari F, Hocking MC, Mccormack SE. A Survey of Patient-Relevant Outcomes in Pediatric Craniopharyngioma: Focus on Hypothalamic Obesity. Front Endocrinol 2022;13:876770. [DOI: 10.3389/fendo.2022.876770] [Reference Citation Analysis]
17 Tessaris D, Matarazzo P, Tuli G, Tuscano A, Rabbone I, Spinardi A, Lezo A, Fenocchio G, Buganza R, de Sanctis L. Multidisciplinary Approach for Hypothalamic Obesity in Children and Adolescents: A Preliminary Study. Children (Basel) 2021;8:531. [PMID: 34206290 DOI: 10.3390/children8070531] [Reference Citation Analysis]
18 Pascual JM, Prieto R, Rosdolsky M. Craniopharyngiomas primarily affecting the hypothalamus. Handb Clin Neurol 2021;181:75-115. [PMID: 34238481 DOI: 10.1016/B978-0-12-820683-6.00007-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Overeem S, van Litsenburg RRL, Reading PJ. Sleep disorders and the hypothalamus. Handb Clin Neurol 2021;182:369-85. [PMID: 34266606 DOI: 10.1016/B978-0-12-819973-2.00025-3] [Reference Citation Analysis]
20 Cordani R, Veneruso M, Napoli F, Di Iorgi N, Milanaccio C, Consales A, Disma N, De Grandis E, Maghnie M, Nobili L. Sleep Disturbances in Pediatric Craniopharyngioma: A Systematic Review. Front Neurol 2022;13:876011. [DOI: 10.3389/fneur.2022.876011] [Reference Citation Analysis]
21 Otte A, Müller HL. Mini-review: Childhood-onset Craniopharyngioma. J Clin Endocrinol Metab 2021:dgab397. [PMID: 34086900 DOI: 10.1210/clinem/dgab397] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Elliott V, Waldrop SW, Wiromrat P, Carreau AM, Green MC. The Interaction of Obesity and Reproductive Function in Adolescents. Semin Reprod Med 2022. [PMID: 35562099 DOI: 10.1055/s-0042-1744495] [Reference Citation Analysis]
23 Cossu G, Jouanneau E, Cavallo LM, Elbabaa SK, Giammattei L, Starnoni D, Barges-Coll J, Cappabianca P, Benes V, Baskaya MK, Bruneau M, Meling T, Schaller K, Chacko AG, Youssef AS, Mazzatenta D, Ammirati M, Dufour H, Laws E, Berhouma M, Daniel RT, Messerer M. Surgical management of craniopharyngiomas in adult patients: a systematic review and consensus statement on behalf of the EANS skull base section. Acta Neurochir (Wien) 2020;162:1159-77. [PMID: 32112169 DOI: 10.1007/s00701-020-04265-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 10.5] [Reference Citation Analysis]
24 Dimitri P. Treatment of Acquired Hypothalamic Obesity: Now and the Future. Front Endocrinol 2022;13:846880. [DOI: 10.3389/fendo.2022.846880] [Reference Citation Analysis]
25 van Schaik J, Pillen S, van Litsenburg RRL, Vandenbussche NLE, de Bont JM, Schouten-van Meeteren AYN, van Santen HM. The importance of specialized sleep investigations in children with a suprasellar tumor. Pituitary 2020;23:613-21. [PMID: 32691357 DOI: 10.1007/s11102-020-01065-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
26 Fouda MA, Zurakowski D, Scott RM, Marcus KJ, Manley PE, Ullrich NJ, Cohen LE, Goumnerova LC. Novel predictive scoring system for morbid hypothalamic obesity in patients with pediatric craniopharyngioma. Childs Nerv Syst 2021;37:403-10. [PMID: 32888069 DOI: 10.1007/s00381-020-04877-z] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Cerbone M, Katugampola H, Simpson HL, Dattani MT. Approach to the Patient: Management of Pituitary Hormone Replacement Through Transition. J Clin Endocrinol Metab 2022;107:2077-91. [PMID: 35262704 DOI: 10.1210/clinem/dgac129] [Reference Citation Analysis]
28 Fouda MA, Day EL, Staffa SJ, Scott RM, Marcus KJ, Baird LC. Postoperative MR imaging surveillance of pediatric craniopharyngioma: new institutional guidelines. Childs Nerv Syst 2021;37:853-61. [PMID: 33011870 DOI: 10.1007/s00381-020-04901-2] [Reference Citation Analysis]
29 Faucher P, Carette C, Jannot AS, Gatta-Cherifi B, Van Straaten A, Piquet MA, Raverot G, Alligier M, Batisse T, Ziegler O, Drui D, Bretault M, Farigon N, Slim K, Genser L, Poghosyan T, Vychnevskaia K, Blanchard C, Robert M, Gronnier C, Poitou C, Czernichow S. Five-Year Changes in Weight and Diabetes Status After Bariatric Surgery for Craniopharyngioma-Related Hypothalamic Obesity: a Case-Control Study. Obes Surg 2022. [PMID: 35524022 DOI: 10.1007/s11695-022-06079-9] [Reference Citation Analysis]
30 Müller HL, Tauber M, Lawson EA, Özyurt J, Bison B, Martinez-Barbera JP, Puget S, Merchant TE, van Santen HM. Hypothalamic syndrome. Nat Rev Dis Primers 2022;8:24. [PMID: 35449162 DOI: 10.1038/s41572-022-00351-z] [Reference Citation Analysis]